| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $20.5M | +54.0% |
| SG&A Expense | $7.6M | +75.8% |
| Interest Expense | $625K | -84.9% |
| Pre-tax Income | -$30.1M | -238.5% |
| Income Tax | $2K | -57.5% |
| Net Income | -$30.1M | -38.6% |
| EPS (Basic) | -$0.63 | +47.9% |
| EPS (Diluted) | -$0.63 | +47.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | -71.4% |
| Current Assets | $4.6M | -76.4% |
| Total Assets | $27.4M | +37.0% |
| Current Liabilities | $5.9M | +11.1% |
| Total Liabilities | $6.4M | +19.5% |
| Stockholders' Equity | $20.9M | +43.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.6M | -87.6% |
| Capital Expenditures | $76K | +31.4% |
| Investing Cash Flow | -$1.3M | +77.9% |
| Financing Cash Flow | $19.9M | -33.1% |
| Free Cash Flow | -$27.7M | -87.4% |